MRI improved LLM-based recurrence prediction after definitive cervical chemoradiotherapy
Multimodal LLM prediction reached an AUC of 0.79, but AI-generated MRI reports showed clinically important discordances requiring expert review.
Multimodal LLM prediction reached an AUC of 0.79, but AI-generated MRI reports showed clinically important discordances requiring expert review.
Three commercial AI models produced broadly usable head-and-neck contours, reducing review time to five minutes, but anatomical definitions differed importantly between vendors.
Ten contemporary multimodal deep-learning studies showed inconsistent external performance, calibration and reporting, limiting clinical use of personalized toxicity prediction.
External validation achieved AUC 0.986, while modeled risk-adapted surveillance reduced visits by 90.0–98.5% and identified every observed failure.
AI can automate particle planning, dose prediction, adaptation and quality assurance, but limited data and validation still constrain clinical adoption.
A model integrating planning CT, 3D dose and tumor contours achieved strong external prediction of distant metastasis but weaker local-recurrence performance.
ASTuTE biomarker testing changed 27.5% of shared decisions and reduced planned short-term ADT use from 37% to 12.5%.
A scoping review maps generative AI across imaging, documentation, QA and decision support while emphasizing major safety and governance gaps.
AI synthetic CT preserved soft-tissue HU and geometry well, while bone, air interfaces and implanted devices remained important failure modes.
Reference-free LLM planning improved hotspot control and boost-target conformity while maintaining organ-at-risk sparing comparable to clinical plans.
An open-source workflow structured 15 years of radiotherapy data, although reirradiation prediction showed only modest discrimination.
The Transformer calculated carbon-ion pencil-beam doses in 14 milliseconds with 98.0% gamma agreement at stringent 1%/1 mm criteria.
AI-assisted planning cut average planning time from about two hours to 30 minutes, but three of 12 plans required manual hotspot correction.
Patient-specific reinforcement learning improved moving-target coverage over static GTV plans while reducing some normal-tissue exposure compared with ITV planning.
A retrieval-augmented GPT-4.1 chatbot rapidly surfaced previous TrueBeam faults, but procedural, role-definition and safety errors remained.